Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 13.70%, which has investors questioning if this is right time to ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

Seattle Children’s partnered with Google Cloud to develop an AI-powered tool called Pathway Assistant. The tool, built using Google’s Gemini models on its Vertex AI platform, is designed to help ...

Researchers hope MindGlide will unlock valuable information from millions of untapped brain images that were previously difficult or impossible to understand.

Trace is partnering with Unlearn as it advances plans for a clinical trial of its treatment candidate that targets the UNC13A ...

Discover how Akero Therapeutics' EFX outshines competitors in MASH treatment, with groundbreaking results and strong ...

Background Infectious agents such as SARS-CoV-2 require strategies to contain outbreaks, particularly in hospitals where the ...

NIH-supported clinical trial shows AI tool as effective as healthcare providers in generating referrals to addiction ...

Recursion Pharmaceuticals, Inc.’s RXRX share price has dipped by 11.85%, which has investors questioning if this is right ...

Xenon Pharmaceuticals Inc.'s XEN1101 shows promise in epilepsy with strong phase 2b results and solid financials. Click here ...

John Beeler, Ph.D., SVP of Business Development at BPGbio, brings over two decades of experience in biotechnology and ...